Kristen Coppock

The prescription-only crofelemer delayed-release tablets were developed using a sustainable, plant-based formula.

Multiple strategies can be used to create an individualized approach to therapies and removing barriers for patients with cancer.

The kinase inhibitor is a promising treatment option for patients with MET exon 14 skipping mutation non–small cell lung cancer.

In voting in favor of the recommendation, 22 committee members unanimously agreed that the benefits of the Johnson & Johnson COVID-19 vaccine outweigh its risks.

The drug, onasemnogene abeparvovec-xioi (Zolgensma, AveXis), is an adeno-associated virus vector-based gene therapy that targets the cause of SMA, a leading genetic cause of infant mortality.

A federal appropriations bill will not include bipartisan provision that would have required drug manufacturers to be more transparent with costs to consumers after it was blocked by House Republicans.

FDA officials have approved the first generic versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy's Laboratories SA) sublingual film to treat opioid dependence.

Agency officials have given the green light to versions of buprenorphine and naloxone (Suboxone, Mylan Technologies Inc and Dr. Reddy's Laboratories SA) sublingual film.

The FDA has approved ILUMYA (tildrakizumab-asmn, Sun Pharma) for treating adults with moderate-to-severe plaque psoriasis.